AI

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

AI

Vultures and AI as death detectors

Jim Cornall - November 25, 2024

AI

Applied AI and deeptech innovations take centre stage at Expand North Star 2024

Jim Cornall - October 28, 2024

AI

Cyngn gets patent for autonomous vehicle technology

Jim Cornall - September 11, 2024

AI

New dawn for AI-powered atomic-scale 3D imaging

Jim Cornall - September 3, 2024

AI

Healthy AI: sustainable artificial intelligence for healthcare

Jim Cornall - August 7, 2024

AI

Report shows researchers trust AI, but want transparency

Jim Cornall - July 25, 2024

AI

Watch: Lymbic AI at Hello Tomorrow

Jim Cornall - June 28, 2024

AI

What is swarm computing?

Jim Cornall - June 3, 2024

1...456 7 Page 5 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0